Advanced search
Publication Cover
Cancer Biology & Therapy Volume 15, 2014 - Issue 8
Submit an article Journal homepage
975
Views
14
CrossRef citations to date
0
Altmetric
Research Paper

Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer

Hyunki Kim Department of Radiology; University of Alabama at Birmingham; Birmingham, AL USA; Department of Biomedical Engineering; University of Alabama at Birmingham; Birmingham, AL USA; Comprehensive Cancer Center; University of Alabama at Birmingham; Birmingham, AL USACorrespondence[email protected] [email protected]
,
Sharon L Samuel Department of Radiology; University of Alabama at Birmingham; Birmingham, AL USA
,
Guihua Zhai Department of Radiology; University of Alabama at Birmingham; Birmingham, AL USA
,
Samir Rana Department of Biomedical Sciences; University of Alabama at Birmingham; Birmingham, AL USA
,
Marie Taylor Department of Radiology; University of Alabama at Birmingham; Birmingham, AL USA
,
Heidi R Umphrey Department of Radiology; University of Alabama at Birmingham; Birmingham, AL USA; Comprehensive Cancer Center; University of Alabama at Birmingham; Birmingham, AL USA
,
Denise K Oelschlager Department of Pathology; University of Alabama at Birmingham; Birmingham, AL USA
,
Donald J Buchsbaum Comprehensive Cancer Center; University of Alabama at Birmingham; Birmingham, AL USA; Department of Radiation Oncology; University of Alabama at Birmingham; Birmingham, AL USA
&
Kurt R Zinn Department of Radiology; University of Alabama at Birmingham; Birmingham, AL USA; Comprehensive Cancer Center; University of Alabama at Birmingham; Birmingham, AL USACorrespondence[email protected] [email protected]
 show all
Pages 1053-1060 | Received 21 Mar 2014, Accepted 09 May 2014, Published online: 19 May 2014

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Valle Palomo & Ana Martinez. (2017) Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015). Expert Opinion on Therapeutic Patents 27:6, pages 657-666.
Read now

Articles from other publishers (13)

Halima Alsamri, Yusra Al Dhaheri & Rabah Iratni. (2023) Targeting Triple-Negative Breast Cancer by the Phytopolyphenol Carnosol: ROS-Dependent Mechanisms. Antioxidants 12:7, pages 1349.
Crossref
Edris Choupani, Mohammad Mahmoudi Gomari, Saeed Zanganeh, Sherko Nasseri, Kaveh Haji-allahverdipoor, Neda Rostami, Yaeren Hernandez, Safa Najafi, Neda Saraygord-Afshari & Arshad Hosseini. (2023) Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review. Pharmacological Reviews 75:2, pages 309-327.
Crossref
Lauren Scarpetti, Chetan C Oturkar, Dejan Juric, Maria Shellock, Giuliana Malvarosa, Kathryn Post, Steven Isakoff, Nancy Wang, Brian Nahed, Kevin Oh, Gokul M Das & Aditya Bardia. (2023) Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant p53. The Oncologist.
Crossref
Mohammed Kaleem, Maryam Perwaiz, Suza Mohammad Nur, Abdulrasheed O. Abdulrahman, Wasim Ahmad, Fahad A. Al-Abbasi, Vikas Kumar, Mohammad Amjad Kamal & Firoz Anwar. (2022) Epigenetics of Triple-Negative Breast Cancer via Natural Compounds. Current Medicinal Chemistry 29:8, pages 1436-1458.
Crossref
Md Abdus Subhan & Vladimir P. Torchilin. (2021) Advances with antibody-drug conjugates in breast cancer treatment. European Journal of Pharmaceutics and Biopharmaceutics 169, pages 241-255.
Crossref
Mark van Barele, Bernadette A. M. Heemskerk-Gerritsen, Yvonne V. Louwers, Mijntje B. Vastbinder, John W. M. Martens, Maartje J. Hooning & Agnes Jager. (2021) Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?. Cancers 13:11, pages 2506.
Crossref
Mamta Kumari, Praveen Thaggikuppe Krishnamurthy & Piyong Sola. (2020) Targeted Drug Therapy to Overcome Chemoresistance in Triple-negative Breast Cancer. Current Cancer Drug Targets 20:8, pages 559-572.
Crossref
Rama Rao Malla, KGK Deepak, Neha Merchant & Venkata Ramesh Dasari. (2020) Breast Tumor Microenvironment: Emerging target of therapeutic phytochemicals. Phytomedicine 70, pages 153227.
Crossref
K.G.K. Deepak, Rahul Vempati, Ganji Purnachandra Nagaraju, Venkata Ramesh Dasari, Nagini S.D.N. Rao & Rama Rao Malla. (2020) Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer. Pharmacological Research 153, pages 104683.
Crossref
Takako Niwa, Yuji Kasuya, Yukie Suzuki, Kimihisa Ichikawa, Hiroko Yoshida, Akiko Kurimoto, Kento Tanaka & Koji Morita. (2018) Novel Immunoliposome Technology for Enhancing the Activity of the Agonistic Antibody against the Tumor Necrosis Factor Receptor Superfamily. Molecular Pharmaceutics 15:9, pages 3729-3740.
Crossref
Romone M. Fancy, Harrison Kim, Tiara Napier, Donald J. Buchsbaum, Kurt R. Zinn & Yuhua Song. (2018) Calmodulin antagonist enhances DR5‐mediated apoptotic signaling in TRA‐8 resistant triple negative breast cancer cells. Journal of Cellular Biochemistry 119:7, pages 6216-6230.
Crossref
Harrison Kim, Donald J. Buchsbaum & Kurt R. Zinn. (2015) A Novel Imaging Biomarker Extracted from Fluorescence Microscopic Imaging of TRA-8/DR5 Oligomers Predicts TRA-8 Therapeutic Efficacy in Breast and Pancreatic Cancer Mouse Models. Molecular Imaging and Biology 18:3, pages 325-333.
Crossref
Fengtao Liu, Yanmin Si, Guangchao Liu, Shulian Li, Jun Zhang & Yuanfang Ma. (2015) The tetravalent anti-DR5 antibody without cross-linking direct induces apoptosis of cancer cells. Biomedicine & Pharmacotherapy 70, pages 41-45.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.